These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35124261)

  • 41. Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays.
    Padoan A; Cosma C; Bonfante F; Della Rocca F; Barbaro F; Santarossa C; Dall'Olmo L; Pagliari M; Bortolami A; Cattelan A; Cianci V; Basso D; Plebani M
    Clin Chem Lab Med; 2022 Feb; 60(3):456-463. PubMed ID: 34911170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study.
    Yamamoto S; Maeda K; Matsuda K; Tanaka A; Horii K; Okudera K; Takeuchi JS; Mizoue T; Konishi M; Ozeki M; Sugiyama H; Aoyanagi N; Mitsuya H; Sugiura W; Ohmagari N
    Clin Infect Dis; 2022 Aug; 75(1):e683-e691. PubMed ID: 34950947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2.
    Newman J; Thakur N; Peacock TP; Bialy D; Elrefaey AME; Bogaardt C; Horton DL; Ho S; Kankeyan T; Carr C; Hoschler K; Barclay WS; Amirthalingam G; Brown KE; Charleston B; Bailey D
    Nat Microbiol; 2022 Aug; 7(8):1180-1188. PubMed ID: 35836002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study.
    Yung CF; Le Bert N; Kam KQ; Saffari SE; Tan CW; Mah YY; Zhang J; Yeoh AY; Zhu F; Hariharaputran S; Chong CY; Bertoletti A; Wang L
    Sci Rep; 2023 Oct; 13(1):17337. PubMed ID: 37833554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2.
    Clairon Q; Prague M; Planas D; Bruel T; Hocqueloux L; Prazuck T; Schwartz O; Thiébaut R; Guedj J
    PLoS Comput Biol; 2023 Aug; 19(8):e1011282. PubMed ID: 37549192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal determination of BNT162b2 vaccine induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of Romanian healthcare workers.
    Korodi M; Horváth I; Rákosi K; Jenei Z; Hudák G; Kákes M; Dallos-Fejér K; Simai E; Páll O; Staver N; Briciu V; Lupșe M; Flonta M; Almaș A; Birlutiu V; Daniela Lupu C; Magdalena Ghibu A; Pianoschi D; Terza LM; Fejer SN
    Vaccine; 2022 Sep; 40(37):5445-5451. PubMed ID: 35931634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint.
    Chen X; Wang W; Chen X; Wu Q; Sun R; Ge S; Zheng N; Lu W; Yang J; Rodewald L; Yu H
    BMC Med; 2022 Jan; 20(1):36. PubMed ID: 35086547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study.
    Cassaniti I; Bergami F; Percivalle E; Gabanti E; Sammartino JC; Ferrari A; Adzasehoun KMG; Zavaglio F; Zelini P; Comolli G; Sarasini A; Piralla A; Ricciardi A; Zuccaro V; Maggi F; Novazzi F; Simonelli L; Varani L; Lilleri D; Baldanti F
    Clin Microbiol Infect; 2022 Feb; 28(2):301.e1-301.e8. PubMed ID: 34582981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutralizing Antibody Activity to Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) and Omicron (B.1.1.529) After 1 or 2 Doses of BNT162b2 Vaccine in Infection-Naive and Previously Infected Individuals.
    Moy JN; Anderson M; Shen X; Fu J; Stec M; Gosha A; Naquiallah D; Kinslow J; Montefiori DC; Cloherty G; Landay A
    J Infect Dis; 2022 Oct; 226(8):1407-1411. PubMed ID: 35759252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma.
    Nooka AK; Shanmugasundaram U; Cheedarla N; Verkerke H; Edara VV; Valanparambil R; Kaufman JL; Hofmeister CC; Joseph NS; Lonial S; Azeem M; Manalo J; Switchenko JM; Chang A; Linderman SL; Roback JD; Dhodapkar KM; Ahmed R; Suthar MS; Neish AS; Dhodapkar MV
    J Clin Oncol; 2022 Sep; 40(26):3057-3064. PubMed ID: 35259002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.
    Ahmed-Belkacem A; Redjoul R; Brillet R; Ahnou N; Leclerc M; López-Molina DS; Soulier A; Gourgeon A; Rodriguez C; Maury S; Pawlotsky JM; Fourati S
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.
    Almendro-Vázquez P; Chivite-Lacaba M; Utrero-Rico A; González-Cuadrado C; Laguna-Goya R; Moreno-Batanero M; Sánchez-Paz L; Luczkowiak J; Labiod N; Folgueira MD; Delgado R; Paz-Artal E
    Front Immunol; 2022; 13():981350. PubMed ID: 36059485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults.
    Erice A; Varillas-Delgado D; Caballero C
    Clin Microbiol Infect; 2022 Jan; 28(1):139.e1-139.e4. PubMed ID: 34508885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines.
    Lu L; Chen LL; Zhang RR; Tsang OT; Chan JM; Tam AR; Leung WS; Chik TS; Lau DP; Choi CY; Fong CH; Cai JP; Tsoi HW; Choi CY; Zhang X; Abdullah SMU; Chan BP; Chan KH; Yuen KY; Hung IF; To KK
    EBioMedicine; 2022 May; 79():103986. PubMed ID: 35398786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents.
    Jahrsdörfer B; Fabricius D; Scholz J; Ludwig C; Grempels A; Lotfi R; Körper S; Adler G; Schrezenmeier H
    Front Immunol; 2021; 12():743422. PubMed ID: 34659239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal dynamics of SARS-CoV-2 anti-receptor binding domain IgG antibodies in a wide population of health care workers after BNT162b2 vaccination.
    Bordi L; Sberna G; Piscioneri CN; Cocchiara RA; Miani A; Grammatico P; Mariani B; Parisi G
    Int J Infect Dis; 2022 Sep; 122():174-177. PubMed ID: 35661687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia.
    Yang SL; Mat Ripen A; Leong CT; Lee JV; Yen CH; Chand AK; Koh K; Abdul Rahim NAB; Gokilavanan V; Mohamed NNEB; Sevalingam RKA; Sulaiman N; Ab Razak AKB; Mohd Nor NHB; Pong MK; Tai KY; Toh V; Woon YL; Peariasamy KM
    Emerg Microbes Infect; 2022 Dec; 11(1):1262-1271. PubMed ID: 35412409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding Domain.
    Lee B; Ko JH; Lee KH; Kim YC; Song YG; Park YS; Baek YJ; Ahn JY; Choi JY; Song KH; Kim ES; Bae S; Kim SH; Jeong HW; Kim SW; Kwon KT; Kim SH; Jeong H; Kim B; Kim SS; Choi WS; Peck KR; Kang ES
    Microbiol Spectr; 2022 Dec; 10(6):e0266922. PubMed ID: 36250875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistence of Immune Response in Health Care Workers After Two Doses BNT162b2 in a Longitudinal Observational Study.
    Herzberg J; Fischer B; Lindenkamp C; Becher H; Becker AK; Honarpisheh H; Guraya SY; Strate T; Knabbe C
    Front Immunol; 2022; 13():839922. PubMed ID: 35309303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.